Suicide is a huge but largely preventable health problem causing almost half of all violent deaths and resulting in one million fatalities each year, as well as economic costs in billions of dollars. Estimates suggest that suicide could rise to 1.5 million by 2020. Globally, suicide represents 1.4% of the global burden of diseases [1]. Suicide is usually a cause of great distress to victim, family, friends, and community and largely to the nation [2, 3].

According to different studies among all suicides over 90% of are explained by mental disorders [4–9] mostly mood disorders, alcohol and substance use disorders [9–12].

A recent review of the literatures estimated that up to 50% of schizophrenic patients attempt suicide and up to 13% of all deaths due to suicide are attributable to schizophrenia [13]. Compared to the general population (suicide prevalence about 1%), people with schizophrenia have a more than eightfold increased risk of suicide [14]. Suicide is the major cause of premature death among individuals with schizophrenia. Evidences indicated that up to 10% of patients with schizophrenia die by suicide [15–17]. Being young, male, and in the early years of the illness and having a history of multiple previous episodes or previous suicide attempts are the common risk factors for suicide in schizophrenia [18–21]. A substantial percentage of patients with schizophrenia also attempt suicide, with estimates of lifetime occurrence ranging from 18 to 55% [8].

Evidences indicated that persons with bipolar disorder are 30 times more likely to make a suicide attempt during their lifetime compared to those with no psychiatric disorder [22]. Close to one-third of persons with bipolar disorder attempt suicide [23, 24]. Researchers estimate that in the general population 29% of bipolar patients made at least one suicide attempt during their lives. In clinical samples, 25–56% of the patients with BD report at least one suicide attempt during their lives and 10–19% die by suicide [22–24]. A number of factors have been reported to be associated with the occurrence of suicide attempts in bipolar disorder and co-morbid substance use disorders (SUDs) [23, 25–27] is among those factors.

In persons with severe mental disorders co-morbid substance use disorders (SUD) are very common throughout the course of illness, with an estimated prevalence of 50–60% [28–31]. Nicotine and alcohol use disorders are particularly common among persons with severe mental disorders [8, 9]. Substance use disorder co-morbidity is eventually associated with worse outcome and higher suicidal risk [29, 30].

Evidences have shown that people with severe mental disorders (SMD) are at higher risk of suicide. However, in low- and middle-income countries (LMIC), including Ethiopia there is limited research concerning suicide attempts and suicide ideations in people with severe mental disorders (SMDs). The objective of this study was to assess suicide and suicide attempts in people with schizophrenia and bipolar disorder.

This study revealed that the magnitude of suicidal ideation and suicide attempts in patients with schizophrenia and bipolar disorder was comparable with study conducted in high-income country settings [13, 14, 22, 24]. In the current study, 119 (44.1%) of schizophrenic participants and 128 (47.1%) of bipolar participants have suicidal ideation and, 56 (20.58%) of schizophrenic participants and 58 (21.32%) of bipolar participants have suicidal attempt. This finding is in agreement with other studies [13, 22, 24].

In this study, both suicidal ideation and attempt were more commonly seen in people with bipolar disorder compared to those with schizophrenia. This finding is in agreement with other studies that reported significantly higher rates of suicide ideation and attempt among patients with bipolar disorder [13, 14, 22, 24].

Suicidal ideation and attempt are common among patients with schizophrenia and bipolar disorder as compared to evidences suicidal ideation and attempt in general population. These findings are in line with other studies that revealed significantly higher suicidal ideation and attempt in patients with severe mental disorder than general population [9, 11, 12, 14].

Our study revealed that patients with severe mental disorders are using different substances. This finding is in line with other studies [20] but higher than [31] and lower than [32, 33]. The possible reasons for this difference might be due to the difference in data collection instrument, socio-demographics and culture. Unlike other studies [32–35], 132 (50.6%) (bipolar patients) and 125 (48.1%) (schizophrenic patients), had used khat in their life time. The possible reasons for this difference might be due to differences in socio-demographics and culture.

Suicidal ideation and attempt were more commonly seen in people with bipolar disorder compared to those with schizophrenia. Co-morbid substance use disorder was a more frequent phenomenon among patients with suicidal ideation and attempt than those without suicidal ideation and attempt was identified in the current study that majority of those who have history of suicidal ideation and attempt have co-occurring substance use disorders as compared to those who have no suicidal ideation and attempt. Co-morbid substance use disorders are common in person with suicidal ideation and attempt. As a result, this indicates the need for further screening and attention of co-morbidity in persons with suicide. Further studies concerning effects and specific relationships between suicide and co-morbid substance use disorders and exploring other factors are recommended.

This study only assessed the descriptive part. It will be better to asses factors associated with suicidal ideation and attempt.